Insys Can't Duck Investor Suit Over Opioid Spray's Financials
Insys Therapeutics Inc. and its top brass largely lost their bid to boot an investor's fraud suit Tuesday when a New York federal judge found the complaint had adequately tied the...To view the full article, register now.
Already a subscriber? Click here to view full article